1 |
0.005% lacripep |
- |
- |
- |
- |
053 1件: 53 💬 |
2 |
0.01% lacripep |
- |
- |
- |
- |
053 1件: 53 💬 |
3 |
0.02% fm, sh |
- |
- |
- |
- |
053 1件: 53 💬 |
4 |
0.02% fm, sh, 0.05% csa |
- |
- |
- |
- |
053 1件: 53 💬 |
5 |
0.02% fm, sh, as |
- |
- |
- |
- |
053 1件: 53 💬 |
6 |
0.9% sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 4件: 6 , 14, 51, 53 💬 |
7 |
13-valent pneumococcal conjugate vaccine |
- |
- |
- |
- |
046 2件: 46, 53 💬 |
8 |
1643368-58-4 |
- |
- |
- |
- |
053 2件: 53, 160 💬 |
9 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
10 |
23-valent pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
013 3件: 13, 46, 53 💬 |
11 |
552-02 |
- |
- |
- |
- |
053 2件: 53, 299 💬 |
12 |
[na] |
- |
- |
- |
- |
006 7件: 6 , 11, 35, 46, 53, 65, 299 💬 |
13 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
14 |
Abatacept placebo |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 2件: 46, 53 💬 |
15 |
Abatacept sc |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
053 1件: 53 💬 |
16 |
Abbv-323 |
- |
- |
- |
- |
053 2件: 53, 97 💬 |
17 |
Acycloguanosine |
Acyclovir |
1件: D00222 D00222 💬 |
- |
- |
046 2件: 46, 53 💬 |
18 |
Alginate |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
053 2件: 53, 299 💬 |
19 |
Allogeneic adipose tissue-derived mesenchymal stem cells expanded |
- |
- |
- |
- |
053 1件: 53 💬 |
20 |
Allogeneic adipose tissue-derived stromal/stem cells |
- |
- |
- |
- |
053 1件: 53 💬 |
21 |
Allogeneic mesenchymal stem cells (allomsc) |
- |
- |
- |
- |
051 2件: 51, 53 💬 |
22 |
Allogeneic stem cell transplant |
- |
- |
- |
- |
053 2件: 53, 56 💬 |
23 |
Aloe vera |
Aloe Vera Leaf |
- |
- |
- |
053 1件: 53 💬 |
24 |
Amg 557/medi5872 |
- |
- |
- |
- |
053 1件: 53 💬 |
25 |
Anti-cd28dab |
- |
- |
- |
- |
049 3件: 49, 53, 160 💬 |
26 |
Anti-pandemic h1n1 influenza vaccine |
- |
- |
- |
- |
046 5件: 46, 49, 50, 51, 53 💬 |
27 |
Artificial saliva |
- |
- |
- |
- |
053 1件: 53 💬 |
28 |
As |
- |
- |
- |
- |
046 6件: 46, 53, 96, 97, 215, 271 💬 |
29 |
Ascs |
- |
- |
- |
- |
053 2件: 53, 96 💬 |
30 |
Autologous serum |
- |
- |
- |
- |
053 1件: 53 💬 |
31 |
Autologous serum 20% |
- |
- |
- |
- |
053 1件: 53 💬 |
32 |
Autologous serum 50% |
- |
- |
- |
- |
053 1件: 53 💬 |
33 |
Autologous stem cell transplant |
- |
- |
- |
- |
053 2件: 53, 56 💬 |
34 |
Aún no establecido |
- |
- |
- |
- |
053 1件: 53 💬 |
35 |
B / phuket / 3073/2013-like virus) |
- |
- |
- |
- |
053 1件: 53 💬 |
36 |
Baminercept |
Baminercept |
1件: D08866 D08866 💬 |
LTB 1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97 💬 |
37 |
Belimumab |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
38 |
Benlysta |
- |
- |
- |
- |
043 5件: 43, 49, 53, 66, 222 💬 |
39 |
Benlysta (belimumab) |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 4件: 11, 49, 53, 222 💬 |
40 |
Benlysta - 120 mg - polvere per concentrato per soluzione per infusione - uso endovenoso - flaconcino (vetro) 120 mg 1 flaconcino |
- |
- |
- |
- |
053 1件: 53 💬 |
41 |
Biopsy of the labial salivary gland |
- |
- |
- |
- |
053 1件: 53 💬 |
42 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
43 |
Bms-188667 |
- |
- |
- |
- |
046 8件: 46, 49, 53, 65, 96, 97, 222, 271 💬 |
44 |
Bms-931699 |
Lulizumab pegol |
- |
- |
- |
049 3件: 49, 53, 160 💬 |
45 |
Bms-986142 |
BMS-986142 |
- |
- |
- |
046 3件: 46, 53, 160 💬 |
46 |
Bms-986195 |
Branebrutinib |
1件: D11478 D11478 💬 |
BTK 1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 3件: 46, 49, 53 💬 |
47 |
Bms986142 |
- |
- |
- |
- |
046 3件: 46, 53, 160 💬 |
48 |
Bms986195 |
- |
- |
- |
- |
046 3件: 46, 49, 53 💬 |
49 |
Branebrutinib |
Branebrutinib |
1件: D11478 D11478 💬 |
BTK 1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 3件: 46, 49, 53 💬 |
50 |
Btk inhibitor |
- |
- |
- |
- |
046 3件: 46, 53, 160 💬 |
51 |
Bupi5 |
- |
- |
- |
- |
053 1件: 53 💬 |
52 |
Bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
53 |
Bupivacaine hydrochloride |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 2件: 46, 53 💬 |
54 |
Bupizenge |
- |
- |
- |
- |
053 1件: 53 💬 |
55 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
56 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
57 |
Calcium carbonate d |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
053 1件: 53 💬 |
58 |
Carbomer |
Carbomer |
- |
- |
- |
053 1件: 53 💬 |
59 |
Carbomer 974p |
Carbomer |
- |
- |
- |
053 1件: 53 💬 |
60 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
61 |
Cathepsin s |
- |
- |
- |
- |
053 1件: 53 💬 |
62 |
Cathepsin s inhibitor |
- |
- |
- |
- |
053 1件: 53 💬 |
63 |
Cdz173 |
- |
- |
- |
- |
053 2件: 53, 65 💬 |
64 |
Cellulose |
Microcrystalline cellulose |
1件: D00093 D00093 💬 |
- |
- |
035 4件: 35, 53, 96, 162 💬 |
65 |
Cevimeline |
Cevimeline |
2件: D00661 D00661, D07667 D07667 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
053 1件: 53 💬 |
66 |
Cfz533 |
- |
- |
- |
- |
011 4件: 11, 46, 49, 53 💬 |
67 |
Cfz533 (iscalimab) |
Iscalimab |
1件: D11610 D11610 💬 |
CD40 1件: CD40 💬 |
Allograft rejection 16件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis |
053 1件: 53 💬 |
68 |
Cfz533 active - cohort 1 |
- |
- |
- |
- |
053 1件: 53 💬 |
69 |
Cfz533 active - cohort 2 |
- |
- |
- |
- |
053 1件: 53 💬 |
70 |
Cfz533 active - cohort 3 |
- |
- |
- |
- |
053 1件: 53 💬 |
71 |
Cfz533 active -cohort 3 |
- |
- |
- |
- |
053 1件: 53 💬 |
72 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
73 |
Ciclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
74 |
Citric acid |
Citric acid |
2件: D00037 D00037, D01222 D01222 💬 |
- |
- |
053 2件: 53, 291 💬 |
75 |
Citric acid based mouthwash |
Citric acid |
2件: D00037 D00037, D01222 D01222 💬 |
- |
- |
053 1件: 53 💬 |
76 |
Co |
- |
- |
- |
- |
006 5件: 6 , 13, 53, 70, 85 💬 |
77 |
Coconut |
Coconut |
- |
- |
- |
013 2件: 13, 53 💬 |
78 |
Cryostor cs10 |
- |
- |
- |
- |
053 1件: 53 💬 |
79 |
Csa |
- |
- |
- |
- |
019 8件: 19, 49, 50, 53, 60, 63, 222, 228 💬 |
80 |
Cscc_asc(22) |
- |
- |
- |
- |
053 1件: 53 💬 |
81 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
82 |
Cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
83 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
84 |
Cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 10件: 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
85 |
Cyclosporins |
- |
- |
- |
- |
053 4件: 53, 60, 65, 222 💬 |
86 |
Dehydroepiandrosterone |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 5件: 49, 53, 83, 96, 113 💬 |
87 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
88 |
Dexamethasone parotid irrigation |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
053 1件: 53 💬 |
89 |
Diquafosol |
Diquafosol |
- |
- |
- |
053 1件: 53 💬 |
90 |
Dornase alfa |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
053 2件: 53, 299 💬 |
91 |
E4 |
- |
- |
- |
- |
053 1件: 53 💬 |
92 |
Efalizumab |
Efalizumab |
1件: D03959 D03959 💬 |
ITGAL 1件: ITGAL 💬 |
Cell adhesion molecules 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 8件: 11, 13, 37, 46, 53, 61, 95, 96 💬 |
93 |
Endura |
Boscalid |
- |
- |
- |
053 1件: 53 💬 |
94 |
Estetrol |
Estetrol |
2件: D11513 D11513, D11514 D11514 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
053 1件: 53 💬 |
95 |
Etanercept |
Etanercept |
1件: D00742 D00742 💬 |
LTA 2件: LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
015 14件: 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬 |
96 |
Filgotinib |
Filgotinib |
1件: D10871 D10871 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 6件: 46, 53, 96, 97, 222, 271 💬 |
97 |
Fmp-30 |
- |
- |
- |
- |
053 1件: 53 💬 |
98 |
Gadoterate |
Gadoteric acid |
1件: D08007 D08007 💬 |
- |
- |
053 1件: 53 💬 |
99 |
Ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 3件: 13, 46, 53 💬 |
100 |
Glycyrrhiza |
Glycyrrhiza glabra |
- |
- |
- |
053 2件: 53, 97 💬 |
101 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
102 |
Gs-4059 |
- |
- |
- |
- |
053 1件: 53 💬 |
103 |
Gs-6034 |
- |
- |
- |
- |
046 4件: 46, 53, 96, 97 💬 |
104 |
Gs-9876 |
- |
- |
- |
- |
046 2件: 46, 53 💬 |
105 |
Gsk2618960 |
- |
- |
- |
- |
053 1件: 53 💬 |
106 |
Gsk2618960 2 mg/kg |
- |
- |
- |
- |
053 1件: 53 💬 |
107 |
Hgs1006, lymphostat-b |
- |
- |
- |
- |
053 1件: 53 💬 |
108 |
Hgs1006, lymphostat-b, monoclonal anti-blys, lsb, benlysta |
- |
- |
- |
- |
049 2件: 49, 53 💬 |
109 |
Hril-2 active |
- |
- |
- |
- |
046 3件: 46, 49, 53 💬 |
110 |
Hyaluronate |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
053 2件: 53, 97 💬 |
111 |
Hyaluronic acid |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
046 5件: 46, 53, 70, 226, 231 💬 |
112 |
Hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 9件: 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
113 |
Hydrocortisone sodium phosphate |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
053 3件: 53, 81, 83 💬 |
114 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
115 |
Ianalumab |
- |
- |
- |
- |
035 5件: 35, 46, 49, 53, 95 💬 |
116 |
Iguratimod |
Iguratimod |
1件: D01146 D01146 💬 |
NFKB1 1件: NFKB1 💬 |
AGE-RAGE signaling pathway in diabetic complications 72件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway |
046 4件: 46, 51, 53, 271 💬 |
117 |
Ikervis |
- |
- |
- |
- |
053 1件: 53 💬 |
118 |
Il-2 |
Human interleukin-2 |
- |
- |
- |
002 6件: 2 , 46, 49, 53, 56, 96 💬 |
119 |
Impact |
- |
- |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
120 |
Inactivated and fragmented influenza vaccine (a / michigan / 45/2015 (h1n1) pdm09-like virus, a / singapore / infimh-16-0019 / 2016 (h3n2) -like virus |
- |
- |
- |
- |
053 1件: 53 💬 |
121 |
Iscalimab |
Iscalimab |
1件: D11610 D11610 💬 |
CD40 1件: CD40 💬 |
Allograft rejection 16件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis |
049 2件: 49, 53 💬 |
122 |
Kct-0809 ophthalmic solution |
- |
- |
- |
- |
053 1件: 53 💬 |
123 |
Korean red ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
053 1件: 53 💬 |
124 |
Lacryvisc |
- |
- |
- |
- |
053 1件: 53 💬 |
125 |
Lanraplenib |
Lanraplenib |
1件: D11596 D11596 💬 |
- |
- |
053 2件: 53, 222 💬 |
126 |
Leflunomide |
Leflunomide |
1件: D00749 D00749 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
127 |
Leflunomide mylan |
Leflunomide |
1件: D00749 D00749 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
053 1件: 53 💬 |
128 |
Leniolisib |
Leniolisib |
1件: D11158 D11158 💬 |
PIK3CA 3件: PIK3CA, PIK3CB, PIK3CD 💬 |
AGE-RAGE signaling pathway in diabetic complications 103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway |
053 2件: 53, 65 💬 |
129 |
Levocarnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 3件: 3 , 53, 97 💬 |
130 |
Levofloxacin |
Levofloxacin |
2件: D00588 D00588, D08120 D08120 💬 |
- |
- |
046 4件: 46, 53, 84, 299 💬 |
131 |
Licorice |
Licorice |
1件: D04365 D04365 💬 |
- |
- |
053 1件: 53 💬 |
132 |
Limphostat-b |
- |
- |
- |
- |
053 1件: 53 💬 |
133 |
Lipitor® |
- |
- |
- |
- |
046 2件: 46, 53 💬 |
134 |
Liposic |
- |
- |
- |
- |
053 1件: 53 💬 |
135 |
Lo2a eye drops |
- |
- |
- |
- |
053 1件: 53 💬 |
136 |
Lou064 |
- |
- |
- |
- |
053 1件: 53 💬 |
137 |
Ly3090106 |
- |
- |
- |
- |
053 1件: 53 💬 |
138 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
139 |
Mabthera (rituximab) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 4件: 13, 46, 49, 53 💬 |
140 |
Mabthera - 1 fiala 500 mg 50 ml |
- |
- |
- |
- |
014 2件: 14, 53 💬 |
141 |
Maxidex |
- |
- |
- |
- |
053 1件: 53 💬 |
142 |
Medi4920 |
- |
- |
- |
- |
053 1件: 53 💬 |
143 |
Meglumine |
Meglumine |
1件: D01796 D01796 💬 |
- |
- |
028 2件: 28, 53 💬 |
144 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
145 |
Methyl cellulose |
Methylcellulose |
2件: D00093 D00093, D04996 D04996 💬 |
- |
- |
053 1件: 53 💬 |
146 |
Metilprednisolone |
- |
- |
- |
- |
011 2件: 11, 53 💬 |
147 |
Mighteaflow |
- |
- |
- |
- |
053 1件: 53 💬 |
148 |
Mizoribine |
Mizoribine |
1件: D01392 D01392 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 8件: 46, 49, 51, 53, 66, 94, 222, 224 💬 |
149 |
Mucosta |
- |
- |
- |
- |
053 1件: 53 💬 |
150 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
151 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
152 |
Mycophenolate sodium |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
053 3件: 53, 66, 222 💬 |
153 |
Nacl 0,9% |
- |
- |
- |
- |
053 1件: 53 💬 |
154 |
Ngx267 |
NGX267 |
- |
- |
- |
053 1件: 53 💬 |
155 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
156 |
Olive |
Olea europaea leaf |
- |
- |
- |
013 3件: 13, 49, 53 💬 |
157 |
Olive oil |
Olea europaea leaf |
1件: D03311 D03311 💬 |
- |
- |
013 3件: 13, 49, 53 💬 |
158 |
Omalizumab |
Omalizumab |
1件: D05251 D05251 💬 |
FCER1A 1件: FCER1A 💬 |
Asthma 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
046 7件: 46, 53, 65, 98, 162, 226, 299 💬 |
159 |
Ophthalmic emulsion |
- |
- |
- |
- |
051 2件: 51, 53 💬 |
160 |
Orencia |
- |
- |
- |
- |
044 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
161 |
Orencia 125 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 3件: 46, 49, 53 💬 |
162 |
Ose-127 |
- |
- |
- |
- |
053 2件: 53, 97 💬 |
163 |
Other: 0.02% fm, sh, tbcl |
- |
- |
- |
- |
053 1件: 53 💬 |
164 |
Other: autologous serum and rebamipide 2% |
Rebamipide |
1件: D01121 D01121 💬 |
- |
- |
053 1件: 53 💬 |
165 |
Other: carboxy methyl cellulose |
Methylcellulose |
2件: D00093 D00093, D04996 D04996 💬 |
- |
- |
053 1件: 53 💬 |
166 |
Other: natural herbs of coconut, aloe vera, and pepperint |
Aloe Vera Leaf |
- |
- |
- |
053 1件: 53 💬 |
167 |
Other: no treatment |
- |
- |
- |
- |
053 2件: 53, 256 💬 |
168 |
P-552 |
- |
- |
- |
- |
053 1件: 53 💬 |
169 |
Pah |
- |
- |
- |
- |
049 3件: 49, 53, 86 💬 |
170 |
Paracetamolo |
- |
- |
- |
- |
002 4件: 2 , 11, 14, 53 💬 |
171 |
Parsaclisib |
Parsaclisib |
1件: D11437 D11437 💬 |
PIK3CD 1件: PIK3CD 💬 |
AGE-RAGE signaling pathway in diabetic complications 103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway |
035 3件: 35, 53, 61 💬 |
172 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
173 |
Pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 3件: 6 , 53, 299 💬 |
174 |
Pilocarpine hydrochloride |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 1件: 53 💬 |
175 |
Plaquenil |
- |
- |
- |
- |
046 4件: 46, 49, 53, 96 💬 |
176 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
177 |
Privigen 100 mg/ml, solution pour perfusion |
- |
- |
- |
- |
053 1件: 53 💬 |
178 |
Privigen® 100mg/ml at the dose of 2g/kg of body weight |
- |
- |
- |
- |
053 1件: 53 💬 |
179 |
Probiotic product - cap |
- |
- |
- |
- |
053 1件: 53 💬 |
180 |
Procedure: minor salivary gland (labial) biopsy |
- |
- |
- |
- |
053 1件: 53 💬 |
181 |
Procedure: mri imaging with intravenous contrast with gadoterate meglumine |
Gadoteric acid |
2件: D01796 D01796, D08007 D08007 💬 |
- |
- |
053 1件: 53 💬 |
182 |
Procedure: pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 1件: 53 💬 |
183 |
Procedure: sialoendoscopy |
- |
- |
- |
- |
053 1件: 53 💬 |
184 |
Prp injection |
- |
- |
- |
- |
053 1件: 53 💬 |
185 |
Radiation: 11c-met pet/ct imaging |
- |
- |
- |
- |
053 1件: 53 💬 |
186 |
Radiation: 18f-fdg pet/ct imaging |
Fludeoxyglucose (18F) |
- |
- |
- |
053 1件: 53 💬 |
187 |
Raptiva |
- |
- |
- |
- |
011 9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
188 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 7件: 11, 13, 46, 53, 61, 95, 96 💬 |
189 |
Ravagalimab |
- |
- |
- |
- |
053 2件: 53, 97 💬 |
190 |
Rc18 160 mg |
- |
- |
- |
- |
013 2件: 13, 53 💬 |
191 |
Rc18 240 mg |
- |
- |
- |
- |
011 2件: 11, 53 💬 |
192 |
Rebamipide |
Rebamipide |
1件: D01121 D01121 💬 |
- |
- |
046 4件: 46, 53, 97, 271 💬 |
193 |
Refresh endura |
Boscalid |
- |
- |
- |
053 1件: 53 💬 |
194 |
Remibrutinib |
- |
- |
- |
- |
053 1件: 53 💬 |
195 |
Restasis |
- |
- |
- |
- |
053 2件: 53, 162 💬 |
196 |
Rituxan (us, canada, japan), mabthera (rest of world) |
- |
- |
- |
- |
053 1件: 53 💬 |
197 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
198 |
Rituximab (anti-cd20) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
053 1件: 53 💬 |
199 |
Rituximab, mabthera |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
053 1件: 53 💬 |
200 |
Ro545-9072/f03 |
- |
- |
- |
- |
053 1件: 53 💬 |
201 |
Ro5459072 |
- |
- |
- |
- |
053 1件: 53 💬 |
202 |
Rslv-132 |
- |
- |
- |
- |
049 2件: 49, 53 💬 |
203 |
S95011 |
- |
- |
- |
- |
053 1件: 53 💬 |
204 |
S95011 concentrate for solution for infusion |
- |
- |
- |
- |
053 1件: 53 💬 |
205 |
Saline |
- |
- |
- |
- |
006 10件: 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
206 |
Sandimmun optoral |
- |
- |
- |
- |
053 2件: 53, 113 💬 |
207 |
Sar441344 |
- |
- |
- |
- |
053 1件: 53 💬 |
208 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
209 |
Sodium hyaluronate |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
053 2件: 53, 97 💬 |
210 |
Softacort |
- |
- |
- |
- |
053 1件: 53 💬 |
211 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 3件: 13, 14, 53 💬 |
212 |
Solu-medrol |
- |
- |
- |
- |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
213 |
Ss-1 |
- |
- |
- |
- |
053 1件: 53 💬 |
214 |
Standard care hyaluronic acid eye drops |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
053 1件: 53 💬 |
215 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
216 |
Svs20 |
- |
- |
- |
- |
053 1件: 53 💬 |
217 |
Systane ultra ud |
- |
- |
- |
- |
053 1件: 53 💬 |
218 |
Tachipirina |
- |
- |
- |
- |
013 2件: 13, 53 💬 |
219 |
Tachipirina - 500 mg compresse20 compresse |
- |
- |
- |
- |
013 2件: 13, 53 💬 |
220 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
221 |
Tcm (gan-lu-yin)gly |
- |
- |
- |
- |
053 1件: 53 💬 |
222 |
Tears naturale forte |
- |
- |
- |
- |
053 1件: 53 💬 |
223 |
Tetracycline |
Tetracycline |
1件: D00201 D00201 💬 |
- |
- |
013 4件: 13, 46, 53, 97 💬 |
224 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
225 |
Thymosin beta 4 |
Thymosin beta-4 |
- |
- |
- |
036 2件: 36, 53 💬 |
226 |
Thymosin beta 4 eye drops |
Thymosin beta-4 |
- |
- |
- |
053 1件: 53 💬 |
227 |
Tibulizumab |
Tibulizumab |
1件: D11127 D11127 💬 |
IL17A 2件: IL17A, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 7件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation |
053 1件: 53 💬 |
228 |
Tibulizumab (ly3090106) |
Tibulizumab |
1件: D11127 D11127 💬 |
IL17A 2件: IL17A, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 7件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation |
053 1件: 53 💬 |
229 |
Tirabrutinib |
Tirabrutinib |
- |
- |
- |
035 3件: 35, 46, 53 💬 |
230 |
Tocilizumab |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
231 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
232 |
Ucb5857 |
- |
- |
- |
- |
053 1件: 53 💬 |
233 |
Ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
234 |
Vay736 |
- |
- |
- |
- |
013 7件: 13, 35, 46, 49, 53, 85, 95 💬 |
235 |
Vay736 antibody |
- |
- |
- |
- |
053 1件: 53 💬 |
236 |
Vay736 higher dose |
- |
- |
- |
- |
053 1件: 53 💬 |
237 |
Vay736 lower dose |
- |
- |
- |
- |
053 1件: 53 💬 |
238 |
Vehicle control |
- |
- |
- |
- |
053 1件: 53 💬 |
239 |
Vib4920 |
- |
- |
- |
- |
046 2件: 46, 53 💬 |
240 |
Vib7734 |
- |
- |
- |
- |
049 4件: 49, 50, 51, 53 💬 |
241 |
Vitamin a |
Vitamin A |
2件: D00069 D00069, D06543 D06543 💬 |
RARA 2件: RARA, RARB 💬 |
Acute myeloid leukemia 8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
013 3件: 13, 53, 90 💬 |
242 |
Vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 11件: 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
243 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
244 |
Xeros |
- |
- |
- |
- |
053 1件: 53 💬 |
245 |
Xylitol |
Xylitol |
1件: D00061 D00061 💬 |
- |
- |
053 2件: 53, 299 💬 |
246 |
Xyzal |
- |
- |
- |
- |
053 1件: 53 💬 |
247 |
Xyzal - 20 compresse ri |
- |
- |
- |
- |
053 1件: 53 💬 |
248 |
Yellow fever vaccine |
Yellow Fever Vaccine |
1件: D06347 D06347 💬 |
- |
- |
040 7件: 40, 44, 46, 50, 51, 52, 53 💬 |
249 |
Yellow fever vaccine (17d) |
Yellow Fever Vaccine |
1件: D06347 D06347 💬 |
- |
- |
040 7件: 40, 44, 46, 50, 51, 52, 53 💬 |